Europe’s biomedical researchers prepare to gather in Belgium
A European Institute for Biomedical Imaging Research (EIBIR)/European Network for Cell Imaging and Tracking Expertise (ENCITE) educational workshop, called “Cells at work: Imaging in health and disease,” will take place May 18-19 at the University of Mons in Belgium.
A European Institute for Biomedical Imaging Research (EIBIR)/European Network for Cell Imaging and Tracking Expertise (ENCITE) educational workshop, called “Cells at work: Imaging in health and disease,” will take place May 18-19 at the University of Mons in Belgium.
ENCITE is a collaborative project coordinated by EIBIR. It is related to the theme “Cooperation health: in vivo image-guidance for cell therapy,” and is supported by the European Commission within the 7th Framework Programme for Research. It started in June 2009, thanks to a financial contribution of €12 million. ENCITE is a four-year project and has 29 project partners from 11 countries with expertise in the field of cell imaging.
The mission of the project is to develop and test new MR and optical imaging methods and biomarkers to get a more comprehensive picture of cell fate and reactions of the immune system, and ultimately to improve and further develop cell therapy for the benefit of the European patient. Details on the interim results can be found here.
The deadline to register is April 20.
For more information, please contact: office@eibir.org.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
